Literature DB >> 27751443

Inflammation and Lymphedema Are Exacerbated and Prolonged by Neuropilin 2 Deficiency.

Patrick Mucka1, Nicholas Levonyak1, Elena Geretti2, Bernadette M M Zwaans1, Xiaoran Li1, Irit Adini2, Michael Klagsbrun2, Rosalyn M Adam3, Diane R Bielenberg4.   

Abstract

The vasculature influences the progression and resolution of tissue inflammation. Capillaries express vascular endothelial growth factor (VEGF) receptors, including neuropilins (NRPs), which regulate interstitial fluid flow. NRP2, a receptor of VEGFA and semaphorin (SEMA) 3F ligands, is expressed in the vascular and lymphatic endothelia. Previous studies have demonstrated that blocking VEGF receptor 2 attenuates VEGFA-induced vascular permeability. The inhibition of NRP2 was hypothesized to decrease vascular permeability as well. Unexpectedly, massive tissue swelling and edema were observed in Nrp2-/- mice compared with wild-type littermates after delayed-type hypersensitivity reactions. Vascular permeability was twofold greater in inflamed blood vessels in Nrp2-deficient mice compared to those in Nrp2-intact littermates. The addition of exogenous SEMA3F protein inhibited vascular permeability in Balb/cJ mice, suggesting that the loss of endogenous Sema3F activity in the Nrp2-deficient mice was responsible for the enhanced vessel leakage. Functional lymphatic capillaries are necessary for draining excess fluid after inflammation; however, Nrp2-mutant mice lacked superficial lymphatic capillaries, leading to 2.5-fold greater fluid retention and severe lymphedema after inflammation. In conclusion, Nrp2 deficiency increased blood vessel permeability and decreased lymphatic vessel drainage during inflammation, highlighting the importance of the NRP2/SEMA3F pathway in the modulation of tissue swelling and resolution of postinflammatory edema.
Copyright © 2016 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27751443      PMCID: PMC5222969          DOI: 10.1016/j.ajpath.2016.07.022

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  52 in total

1.  Soluble neuropilin targeted to the skin inhibits vascular permeability.

Authors:  Roni Mamluk; Michael Klagsbrun; Michael Detmar; Diane R Bielenberg
Journal:  Angiogenesis       Date:  2005-11-19       Impact factor: 9.596

Review 2.  Receptors for collapsin/semaphorins.

Authors:  H Fujisawa; T Kitsukawa
Journal:  Curr Opin Neurobiol       Date:  1998-10       Impact factor: 6.627

3.  β-Adrenergic receptor antagonists inhibit vasculogenesis of embryonic stem cells by downregulation of nitric oxide generation and interference with VEGF signalling.

Authors:  Fatemeh Sharifpanah; Fatjon Saliu; Mohamed M Bekhite; Maria Wartenberg; Heinrich Sauer
Journal:  Cell Tissue Res       Date:  2014-08-19       Impact factor: 5.249

4.  Aberrant sensory innervation of the olfactory bulb in neuropilin-2 mutant mice.

Authors:  Andreas Walz; Ivan Rodriguez; Peter Mombaerts
Journal:  J Neurosci       Date:  2002-05-15       Impact factor: 6.167

5.  Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype.

Authors:  Diane R Bielenberg; Yasuhiro Hida; Akio Shimizu; Arja Kaipainen; Michael Kreuter; Caroline Choi Kim; Michael Klagsbrun
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

6.  Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor.

Authors:  S Soker; S Takashima; H Q Miao; G Neufeld; M Klagsbrun
Journal:  Cell       Date:  1998-03-20       Impact factor: 41.582

7.  Site-directed mutagenesis in the B-neuropilin-2 domain selectively enhances its affinity to VEGF165, but not to semaphorin 3F.

Authors:  Elena Geretti; Akio Shimizu; Peter Kurschat; Michael Klagsbrun
Journal:  J Biol Chem       Date:  2007-06-26       Impact factor: 5.157

8.  Semaphorin-3A and semaphorin-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis.

Authors:  Noga Guttmann-Raviv; Niva Shraga-Heled; Asya Varshavsky; Cinthya Guimaraes-Sternberg; Ofra Kessler; Gera Neufeld
Journal:  J Biol Chem       Date:  2007-06-14       Impact factor: 5.157

9.  GATA2 and Lmo2 control angiogenesis and lymphangiogenesis via direct transcriptional regulation of neuropilin-2.

Authors:  Silvia Coma; Marc Allard-Ratick; Tomoshige Akino; Laurens A van Meeteren; Akiko Mammoto; Michael Klagsbrun
Journal:  Angiogenesis       Date:  2013-07-28       Impact factor: 9.596

10.  A requirement for neuropilin-1 in embryonic vessel formation.

Authors:  T Kawasaki; T Kitsukawa; Y Bekku; Y Matsuda; M Sanbo; T Yagi; H Fujisawa
Journal:  Development       Date:  1999-11       Impact factor: 6.868

View more
  12 in total

Review 1.  The intragraft microenvironment as a central determinant of chronic rejection or local immunoregulation/tolerance.

Authors:  Johannes Wedel; Hironao Nakayama; Nora M Kochupurakkal; Josephine Koch; Michael Klagsbrun; Diane R Bielenberg; David M Briscoe
Journal:  Curr Opin Organ Transplant       Date:  2017-02       Impact factor: 2.640

2.  Neuropilin-2 regulates airway inflammatory responses to inhaled lipopolysaccharide.

Authors:  Robert M Immormino; David C Lauzier; Hideki Nakano; Michelle L Hernandez; Neil E Alexis; Andrew J Ghio; Stephen L Tilley; Claire M Doerschuk; David B Peden; Donald N Cook; Timothy P Moran
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-04-19       Impact factor: 5.464

3.  Quantitative Assessment of the Apical and Basolateral Membrane Expression of VEGFR2 and NRP2 in VEGF-A-stimulated Cultured Human Umbilical Vein Endothelial Cells.

Authors:  Esmeralda K Bosma; Shahan Darwesh; Jia Y Zheng; Cornelis J F van Noorden; Reinier O Schlingemann; Ingeborg Klaassen
Journal:  J Histochem Cytochem       Date:  2022-07-25       Impact factor: 4.137

Review 4.  Neuropilin 1 Regulation of Vascular Permeability Signaling.

Authors:  Alison Domingues; Alessandro Fantin
Journal:  Biomolecules       Date:  2021-04-29

Review 5.  Class-3 Semaphorins and Their Receptors: Potent Multifunctional Modulators of Tumor Progression.

Authors:  Shira Toledano; Inbal Nir-Zvi; Rotem Engelman; Ofra Kessler; Gera Neufeld
Journal:  Int J Mol Sci       Date:  2019-01-28       Impact factor: 5.923

6.  The noncoding and coding transcriptional landscape of the peripheral immune response in patients with COVID-19.

Authors:  Hao Tang; Yuehan Gao; Zhaohuai Li; Yushan Miao; Zhaohao Huang; Xiuxing Liu; Lihui Xie; He Li; Wen Wen; Yingfeng Zheng; Wenru Su
Journal:  Clin Transl Med       Date:  2020-10

Review 7.  Potential crosstalk between sonic hedgehog-WNT signaling and neurovascular molecules: Implications for blood-brain barrier integrity in autism spectrum disorder.

Authors:  Evelyne Gozal; Rekha Jagadapillai; Jun Cai; Gregory N Barnes
Journal:  J Neurochem       Date:  2021-08-06       Impact factor: 5.546

Review 8.  Emerging Roles for Neuropilin-2 in Cardiovascular Disease.

Authors:  Jennifer L Harman; Jacob Sayers; Chey Chapman; Caroline Pellet-Many
Journal:  Int J Mol Sci       Date:  2020-07-21       Impact factor: 6.208

9.  NRP2 as an Emerging Angiogenic Player; Promoting Endothelial Cell Adhesion and Migration by Regulating Recycling of α5 Integrin.

Authors:  Abdullah A A Alghamdi; Christopher J Benwell; Samuel J Atkinson; Jordi Lambert; Robert T Johnson; Stephen D Robinson
Journal:  Front Cell Dev Biol       Date:  2020-05-26

Review 10.  miRNAs, from Evolutionary Junk to Possible Prognostic Markers and Therapeutic Targets in COVID-19.

Authors:  Brandon Bautista-Becerril; Guillermo Pérez-Dimas; Paola C Sommerhalder-Nava; Alejandro Hanono; Julio A Martínez-Cisneros; Bárbara Zarate-Maldonado; Evangelina Muñoz-Soria; Arnoldo Aquino-Gálvez; Manuel Castillejos-López; Armida Juárez-Cisneros; Jose S Lopez-Gonzalez; Angel Camarena
Journal:  Viruses       Date:  2021-12-27       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.